Rational redesign of inhibitors of furin/kexin processing proteases by electrostatic mutations

Acta Pharmacologica Sinica

Volumn 25, Issue 12, 2004, Pages 1712-1718

  Cai, Xiao Hui ^a   Zhang, Qing ^a   Ding, Da Fu ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Drug design; Eglin c; Electrostatic mutation; Furin; Kexin

Indexed keywords

EGLIN C; FURIN; KEXIN; MUTANT PROTEIN; PROTEINASE;

ARTICLE; DNA TEMPLATE; DRUG DESIGN; ELECTRIC POTENTIAL; MATHEMATICAL MODEL; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; X RAY CRYSTALLOGRAPHY;

ANIMALS; DRUG DESIGN; DRUG INTERACTIONS; ELECTROSTATICS; FURIN; HUMANS; MICE; MOLECULAR STRUCTURE; PROTEINS; SERPINS;

EID: 10344233702     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Liu ZX, Fei H, Chi CW. Two engineered eglin c mutants potently and selectively inhibiting kexin or furin. FEBS Lett 2004; 556: 116-20.
2. Thomas G. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 2002; 3: 753-66.
3. Fei H, Li Y, Wang LX, Luo MJ, Ling MH, Chi CW. Nonhistone protein purified from porcine kidney acts as a suicide substrate inhibitor on furin-like enzyme. Acta Pharmacol Sin 2000; 21: 265-70.
4. Komiyama T, Fuller RS. Engineered eglin c variants inhibit yeast and human proprotein processing proteases, Kex2 and furin. Biochemistry 2000; 39: 15156-65.
5. Rockwell NC, Krysan DJ, Komiyama T, Fuller RS. Precursor processing by kex2/furin proteases. Chem Rev 2002; 102: 4525-48.
6. Fei H, Luo MJ, Ye YZ, Ding DF, Chi CW. The inhibitory activities of recombinant eglin C mutants on kexin and furin, using site-directed mutagenesis and molecular modeling. Acta Biochim Biophys Sin 2001; 33: 591-9.
7. Ye YZ, Fei H, Ding DF. Rational redesign of inhibitors of furin/kexin processing proteases. Acta Biochim Biophys Sin 2001; 33: 504-12.
8. Siezen RJ, Leunissen JA. Subtilases: the superfamily of subtilisin-like serine proteases. Protein Sci 1997; 6: 501-23.
9. Siezen RJ, Creemers JW, Van de Ven WJ. Homology modelling of the catalytic domain of human furin. A model for the eukaryotic subtilisin-like proprotein convertases. Eur J Biochem 1994; 222: 255-66.
10. Henrich S, Cameron A, Bourenkov GP, Kiefersauer R, Huber R, Lindberg I, et al. The crystal structure of the proprotein processing proteinase furin explains its stringent specificity. Nat Struct Biol 2003; 10: 520-6.
11. Holyoak T, Wilson MA, Fenn TD, Kettner CA, Petsko GA, Fuller RS, et al. 2.4 Å resolution crystal structure of the prototypical hormone-processing protease Kex2 in complex with an Ala-Lys-Arg boronic acid inhibitor. Biochemistry 2003; 42: 6709-18.
12. Holyoak T, Kettner CA, Petsko GA, Fuller RS, Ringe D. Structural basis for differences in substrate selectivity in Kex2 and furin protein convertases. Biochemistry 2004; 43: 2412-21.
13. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993; 234: 779-815.
14. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993; 26: 283-91.
15. Ye YZ, Tang HX, Ding DF. Engineering novel functional proteins grafting active sites into natural scaffolds. Acta Biochim Biophys Sin 1999; 31: 303-08.
16. Ye YZ, Tang HX, Ding DF. Design of protein cores by screening combinatorial sequence library. Acta Biochim Biophys Sin 1998; 30: 525-39.
17. Zhou HX. Theory and simulation of the influence of diffusion in enzyme-catalyzed reactions. J Phys Chem. B 1997; 101: 6642-51.
18. Zhou HX, Wong KY, Vijayakumar M. Design of fast enzymes by optimizing interaction potential in active site. Proc Natl Acad Sci USA 1997; 94: 12372-7.
19. Selzer T, Albeck S, Schreiber G. Rational design of faster associating and tighter binding protein complexes. Nat Struct Biol 2000; 7: 537-41.
20. Selzer T, Schreiber G. New insights into the mechanism of protein-protein association. Proteins 2001; 45: 190-8.
21. Selzer T, Schreiber G. Predicting the rate enhancement of protein complex formation from the electrostatic energy of interaction. J Mol Biol 1999; 287: 409-19.
22. Heinz DW, Hyberts SG, Peng JW, Priestle JP, Wagner G, Grutter MG. Changing the inhibitory specificity and function of the proteinase inhibitor eglin c by site-directed mutagenesis: functional and structural investigation. Biochemistry 1992; 31: 8755-66.
23. Lu WY, Starovasnik MA, Dwyer JJ, Kossiakoff AA, Kent SB, Lu W. Deciphering the role of the electrostatic interactions involving Gly70 in eglin C by total chemical protein synthesis. Biochemistry 2000; 39: 3575-84.